Drug Type Unknown |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 1 | Belgium | 20 Sep 2021 |
Not Applicable | - | - | (Wild-type B cells) | lepecgyvbj(hmowrsnyru) = failed to fully upregulate MYC compared to WT cells zukxfcmbdd (hmcrsgfkce ) View more | - | 01 May 2021 | |
Not Applicable | - | - | (Wild-type B cells) | uisviekrdr(lfybjoldgt) = rkbblxjttq zxvkghhfzd (odcuwnsezy ) | - | 01 May 2019 | |
Not Applicable | - | - | (Wildtype B cells) | szywvmvcfh(hpeueuzfim) = mqnrydszvv aeofrrdpzs (ovexhfdqau ) | - | 01 May 2018 |